Health
Covid-19: Pfizer vaccine provides 90% protection against infection in children aged 5-11, study finds – The BMJ
Children aged 5-11 who are given a low dose of the Pfizer-BioNTech mRNA vaccine produced good antibody responses with no reported…
Children aged 5-11 who are given a low dose of the Pfizer-BioNTech mRNA vaccine produced good antibody responses with no reported serious adverse effects, researchers have shown.
The research, published in the New England Journal of Medicine,1 found that…
Continue Reading